Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: Results from two randomized, placebo-controlled trials.
British Journal of Haematology.
Times cited: 87
Treatment of cancer chemotherapy‐associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma.
Times cited: 94